Jul 31, 2025 | Press Releases
Analysis reveals strategic opportunities for pharmaceutical leaders to close treatment gaps and accelerate breakthroughs in underserved rare disease communities. Cambridge, MA, July 31, 2025 — TriNetX, driven by its vision of a connected world where data and...
Jul 10, 2025 | Press Releases
Real-world data (RWD), artificial intelligence (AI), and patient-centric trial design lead pharma priorities in 2025, but data compatibility, regulatory hurdles, and security concerns threaten to stall momentum. CAMBRIDGE, MA – July 10, 2025 – As...
Feb 12, 2025 | Press Releases
Partnership taps real-world data to accelerate clinical trials, research, and drug development in Japan. Cambridge, MA, February 12, 2025 — TriNetX, a global leader in real-world data (RWD) and real-world evidence (RWE) solutions, has partnered with Fujitsu,...
Jan 9, 2025 | Press Releases
After 11 Years, Gadi Lachman to Conclude Operating Role, Remain on TriNetX’s Board CAMBRIDGE, MA – January 9, 2025 – TriNetX, the largest global source of real-world data, today announced that Gadi Lachman, the Company’s Founder, President and CEO, will step...
Sep 18, 2024 | Press Releases
Company recognized with high-level certification for abiding by Spain’s strongest data security measures, sets a new standard for healthcare data protection within its TriNetX LIVE™ platform. Cambridge, MA, September 18, 2024 — TriNetX®, a leader in...
Dec 18, 2023 | News, Press Releases
Cambridge, MA, December 18, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has been named to the 2023 Fortune Impact 20 list. The selection tabs TriNetX as one of the top 20...
